RIPOR2 and cervical cancer: In addition, the evaluation of RIPOR2 expression in cervical cancer cases (n = 19) showed that the low expression of RIPOR2 was associated with a worse OS, although no significant results were obtained, probably due to the lack of an adequate number of samples available; therefore, a larger cohort of CC samples is required to ascertain this association (Figure 12B).